Breaking down the latest mpox vaccination survey results
December 17, 2024
A 2024 survey by the California HIV Research Policy and Research Centers highlights disparities in mpox vaccination among Southern California's LGBTQ+ communities. Conducted at Pride events, the survey found that 74% of vaccinated respondents identified as gay, with Latin American (41%) and Black (18%) groups notably under-vaccinated despite facing higher infection rates. Behavioral adjustments, such as reducing sexual partners and attending fewer events, were common preventive measures. Dr. Ian Holloway of UCLA emphasized the urgency of culturally tailored outreach, particularly after the first U.S. clade 1 mpox case. Initiatives like StickItIn.LA aim to build trust and combat stigma through community-informed strategies.
In 2024, the California HIV Research Policy and Research Centers conducted a survey at Pride events across Southern California, revealing critical insights into mpox vaccination behaviors among LGBTQ+ communities. Of the 255 respondents, 74% of those vaccinated identified as gay, with 41% being Latin American, 36% White, and 18% Black. These findings underscore persistent racial disparities in vaccination rates, particularly among Black and Latinx individuals, who are disproportionately affected by mpox.
Dr. Ian Holloway of UCLA highlighted that while these groups face higher infection risks, they report lower vaccination coverage than their White counterparts. He emphasized the pressing need for culturally specific outreach to bridge this gap, especially after California’s first confirmed U.S. case of clade 1 mpox in San Francisco in 2024.
The survey also found that vaccination alone wasn’t the sole protective strategy. About 20% of respondents reduced sexual partners, while others reported avoiding sex venues, group encounters, and one-time sexual contacts. Notably, 32% relied on social media for information, while 30% consulted healthcare providers.
The initiative StickItIn.LA, launched in partnership with the research center, aims to strengthen trust through direct community engagement and tailored messaging. “We’re creating a platform to listen and connect to those directly impacted,” said Dr. Holloway.
These findings highlight the intersection of health equity, education, and public trust. Addressing mpox requires culturally competent outreach, especially in communities historically underserved by healthcare systems. With new cases of clade 1 mpox emerging, proactive strategies that reduce stigma and misinformation are essential. The survey serves as a call to action for public health leaders to ensure equitable access to vaccines and healthcare resources, safeguarding all communities from future outbreaks.